Topics

Glioblastoma | Outcomes | Survival

Home > Publications > Topics > Glioblastoma > Outcomes > Survival

Gonçalves JM, Ferreira F, Carvalho B, Polónia P, Linhares P.
Survival Determinants in Glioblastoma: An Insight into Biopsy-Only Patient Outcomes.
Biomedicines. 2024 Oct 13;12(10):2327. doi: 10.3390/biomedicines12102327. PMID: 39457639. Observational study. ˍ

Alirezaei Z, Amouheidari A, BasirianJahromi R, Seyyedhosseini S, Hamidi A.
Survival Analysis of Glioblastoma: A Scientometric Perspective.
World Neurosurg. 2024 Nov 20:S1878-8750(24)01919-3? doi: 10.1016/j.wneu.2024.11.059? PMID: 39577630. Bibliometric analysis˰ ˍ

Pohan RA, Khadijah K, Pohan PBA, Aditya RS, Ramadhani E, Saputra R, Astuti RD.
Survival in elderly glioblastoma patients: The often overlooked role of radiotherapy and chemotherapy.
J Clin Neurosci. 2025 Jan 29:111091. doi: 10.1016/j.jocn.2025.111091. PMID: 39880728. Observational study˰ ˍ

Overall survival in newly diagnosed GBM

Shah S, Nag A, Lucke-Wold B.
Association of tumor treating fields (TTFields) therapy with overall survival in newly diagnosed glioblastoma.
Clin Transl Oncol. 2025 Feb 1. doi: 10.1007/s12094-025-03849-6. PMID: 39893330. Review˰ ˍ

IDH-wildtype

Pham J, Cote DJ, Kang K, Briggs RG, Gomez D, Prasad A, Daggupati S, Sisti J, Chow F, Attenello F, Chen CC, Zada G.
Treatment practices and survival outcomes for IDH-wildtype glioblastoma patients according to MGMT promoter methylation status: insights from the U.S. National Cancer Database.
J Neurooncol. 2025 Feb 5. doi: 10.1007/s11060-025-04952-y. PMID: 39907975. Observational study. ˍ